Phase Ⅰ/Ⅱ Clinical Study to Evaluate ABO2011 in Advanced Solid Tumors

NCT06088004 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

218

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumor, Adult

Interventions

DRUG: ABO2011 Injection
DRUG: Toripalimab

Sponsor

Suzhou Abogen Biosciences Co., Ltd.

Collaborators

[object Object]